Loading clinical trials...
Loading clinical trials...
Childhood ADHD and comorbid oppositional defiant disorder (ODD) and conduct disorder (CD) are considered risk factors for subsequent substance abuse, and youth with both ADHD and ODD/CD are at greates...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Jeffrey Newcorn
Collaborators
NCT04631042 · Typical Development, Obsessive Compulsive Disorder, and more
NCT06627764 · Substance Abuse, Intimate Partner Violence (IPV), and more
NCT07478458 · ADHD - Attention Deficit Disorder With Hyperactivity
NCT07466784 · Opioid Use Disorder, Opioid Abuse or Dependence, and more
NCT06655610 · ADHD - Attention Deficit Disorder With Hyperactivity
Icahn School of Medicine at Mount Sinai
New York, New York
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions